31-10-2017 12:40 via genengnews.com

Mustang Bio Plans Manufacturing Facility in Worcester, MA

Cancer immunotherapy developer Mustang Bio has agreed to lease space within UMass Medicine Science Park in Worcester, MA, for a manufacturing facility intended to support the clinical development and commercialization of the company’s chimeric antigen receptor T-cell (CAR-T) product candidates.Mustang Bio, a subsidiary of Fortress Biotech, will lease 27,043 square feet at the park through November 2026, subject to two additional extensions for five years each at Mustang’s option, the
Read more »